Elite Pharmaceuticals, Inc.
ELTP
$0.5475
-$0.0074-1.33%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.74M | 11.32M | 8.29M | 9.56M | 8.41M |
| Total Receivables | 36.22M | 29.21M | 18.45M | 21.44M | 20.49M |
| Inventory | 19.36M | 16.24M | 20.16M | 14.16M | 13.83M |
| Prepaid Expenses | 547.90K | 976.40K | 1.14M | 130.40K | 435.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 77.86M | 57.74M | 48.05M | 45.29M | 43.16M |
|
|
|||||
| Total Current Assets | 77.86M | 57.74M | 48.05M | 45.29M | 43.16M |
| Net Property, Plant & Equipment | 13.81M | 14.10M | 13.87M | 14.28M | 14.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 289.00K | 289.00K | 289.00K | 289.00K | 289.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.38M | 24.26M | 28.55M | 28.34M | 29.63M |
| Total Assets | 111.34M | 96.39M | 90.76M | 88.20M | 87.85M |
|
|
|||||
| Total Accounts Payable | 5.09M | 2.96M | 5.84M | 1.98M | 2.61M |
| Total Accrued Expenses | 3.83M | 3.45M | 3.21M | 5.28M | 5.53M |
| Short-term Debt | -- | 4.00M | 4.00M | 4.00M | 4.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.09M | 1.08M | 1.12M | 1.15M | 1.17M |
| Total Finance Division Other Current Liabilities | 755.60K | 346.20K | 514.80K | 433.10K | 712.40K |
| Total Other Current Liabilities | 755.60K | 346.20K | 514.80K | 433.10K | 712.40K |
| Total Current Liabilities | 10.76M | 11.84M | 14.69M | 12.85M | 14.01M |
|
|
|||||
| Total Current Liabilities | 10.76M | 11.84M | 14.69M | 12.85M | 14.01M |
| Long-Term Debt | 3.01M | 3.03M | 3.05M | 3.08M | 3.24M |
| Short-term Debt | -- | 4.00M | 4.00M | 4.00M | 4.00M |
| Capital Leases | 2.57M | 2.80M | 3.00M | 3.17M | 3.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 47.31M | 25.20M | 33.57M | 21.84M | 9.08M |
| Total Liabilities | 63.66M | 42.87M | 54.31M | 40.93M | 29.60M |
|
|
|||||
| Common Stock & APIC | 174.58M | 174.53M | 174.45M | 174.38M | 174.33M |
| Retained Earnings | -126.59M | -120.70M | -137.70M | -126.81M | -115.77M |
| Treasury Stock & Other | -306.80K | -306.80K | -306.80K | -306.80K | -306.80K |
| Total Common Equity | 47.68M | 53.52M | 36.45M | 47.27M | 58.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.68M | 53.52M | 36.45M | 47.27M | 58.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 47.68M | 53.52M | 36.45M | 47.27M | 58.25M |
|
|
|||||